Matches in Wikidata for { <http://www.wikidata.org/entity/Q91421155> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q91421155 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q91421155 description "im März 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91421155 description "scientific article published on 05 March 2019" @default.
- Q91421155 description "wetenschappelijk artikel" @default.
- Q91421155 description "наукова стаття, опублікована 5 березня 2019" @default.
- Q91421155 name "Trough (C0) and 2-hour postdose (C2) cyclosporine monitoring in patients with moderate-to-severe psoriasis" @default.
- Q91421155 name "Trough (C0) and 2-hour postdose (C2) cyclosporine monitoring in patients with moderate-to-severe psoriasis" @default.
- Q91421155 type Item @default.
- Q91421155 label "Trough (C0) and 2-hour postdose (C2) cyclosporine monitoring in patients with moderate-to-severe psoriasis" @default.
- Q91421155 label "Trough (C0) and 2-hour postdose (C2) cyclosporine monitoring in patients with moderate-to-severe psoriasis" @default.
- Q91421155 prefLabel "Trough (C0) and 2-hour postdose (C2) cyclosporine monitoring in patients with moderate-to-severe psoriasis" @default.
- Q91421155 prefLabel "Trough (C0) and 2-hour postdose (C2) cyclosporine monitoring in patients with moderate-to-severe psoriasis" @default.
- Q91421155 P1433 Q91421155-60530750-6BC2-46D1-BB26-F07185777B2C @default.
- Q91421155 P1476 Q91421155-40F0EE44-6750-4F61-98EE-CE28C8255769 @default.
- Q91421155 P2093 Q91421155-04FBCF2A-105E-404C-82DC-E14C66FA7B14 @default.
- Q91421155 P2093 Q91421155-18D62028-631C-4AB6-B83E-58E361FC19D3 @default.
- Q91421155 P2093 Q91421155-54F74DA0-9339-4527-9A27-3C5D974C2FC9 @default.
- Q91421155 P2093 Q91421155-97DE1355-138A-47E5-98B3-17F7258388EF @default.
- Q91421155 P2093 Q91421155-C222E28C-A0CA-4936-9875-511E631F4185 @default.
- Q91421155 P2093 Q91421155-D836C985-69AA-49BF-BFAF-F264F70820A8 @default.
- Q91421155 P2093 Q91421155-DFCC3842-D0EF-44B7-BD23-54818BB2DBF2 @default.
- Q91421155 P304 Q91421155-411FF15F-5A90-4855-998E-57A617D06BE2 @default.
- Q91421155 P31 Q91421155-9C422A62-9AB9-48CA-8621-6FFF72B8B2EB @default.
- Q91421155 P356 Q91421155-E63E9DB6-35F2-4B01-907F-619F89A2FC89 @default.
- Q91421155 P433 Q91421155-3E5FB8C9-D9B5-442B-85D5-7D41D2F712D0 @default.
- Q91421155 P478 Q91421155-F11F4C38-7144-4A2B-933F-37868288AC27 @default.
- Q91421155 P577 Q91421155-BAE376EA-1C6D-4B98-9858-2B3162D19C1E @default.
- Q91421155 P698 Q91421155-50FF8461-02EC-4791-A1C6-F739D92EE52E @default.
- Q91421155 P921 Q91421155-98DEEFDF-6AA4-48C6-85C4-6AA2E3F67E5E @default.
- Q91421155 P356 JDV.15481 @default.
- Q91421155 P698 30735587 @default.
- Q91421155 P1433 Q15760872 @default.
- Q91421155 P1476 "Trough (C0) and 2-hour postdose (C2) cyclosporine monitoring in patients with moderate-to-severe psoriasis" @default.
- Q91421155 P2093 "A Reolid" @default.
- Q91421155 P2093 "E Daudén" @default.
- Q91421155 P2093 "E Muñoz-Aceituno" @default.
- Q91421155 P2093 "J Pedraz" @default.
- Q91421155 P2093 "M Herrero-Moyano" @default.
- Q91421155 P2093 "P Chicharro" @default.
- Q91421155 P2093 "S Lara" @default.
- Q91421155 P304 "e215-e217" @default.
- Q91421155 P31 Q13442814 @default.
- Q91421155 P356 "10.1111/JDV.15481" @default.
- Q91421155 P433 "5" @default.
- Q91421155 P478 "33" @default.
- Q91421155 P577 "2019-03-05T00:00:00Z" @default.
- Q91421155 P698 "30735587" @default.
- Q91421155 P921 Q367700 @default.